Adenaocortical Carcinoma
1 clinical trials · Condition
◉ Watch Adenaocortical Carcinoma
| Record | Firm | Date |
|---|---|---|
| Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors (NCT00011414) | National Cancer Institute (NCI) | 2001-02-15 |
Track Adenaocortical Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.